Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD (Non-alcoholic Fatty Liver Disease)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableUnknownNCT04463667
What this trial is testing

Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverNAFLD
National Taiwan University Hospital 100
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Testing effectiveness (Phase 2)Study completedNCT00586911
What this trial is testing

Betaine in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Mayo Clinic 26
Not applicableStudy completedNCT02682173
What this trial is testing

Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
University Hospital, Basel, Switzerland 15
Early research (Phase 1)Study completedNCT04561245
What this trial is testing

ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability

Who this might be right for
ObesityNonalcoholic Steatohepatitis
Altimmune, Inc. 100
Not applicableUnknownNCT04240145
What this trial is testing

Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Gehad Abd Elaziz Mhmoud Ahmad 35
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Not applicableStudy completedNCT05209100
What this trial is testing

Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
AdventHealth Translational Research Institute 38
Early research (Phase 1)Study completedNCT06716905
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

Who this might be right for
Non-alcoholic Steatohepatitis
Xiamen Amoytop Biotech Co., Ltd. 72
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Not applicableUnknownNCT02644239
What this trial is testing

Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy

Who this might be right for
EpilepsyCardiovascular DiseaseNon-alcoholic Fatty Liver Disease+1 more
University of Sao Paulo 60
Not applicableUnknownNCT01922830
What this trial is testing

Probiotics and Microbiota in Bariatric Surgery

Who this might be right for
NAFLD
Tel-Aviv Sourasky Medical Center 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04822181
What this trial is testing

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Novo Nordisk A/S 1,205
Post-approval studies (Phase 4)Study completedNCT04977661
What this trial is testing

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Kafrelsheikh University 102
Testing effectiveness (Phase 2)Study completedNCT04210245
What this trial is testing

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 160
Testing effectiveness (Phase 2)Study completedNCT05463575
What this trial is testing

Ketohexokinase Inhibition in NAFLD

Who this might be right for
NAFLD
Maastricht University Medical Center 15
Not applicableStudy completedNCT03490370
What this trial is testing

Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisInsulin Sensitivity
NHS Tayside 8
Testing effectiveness (Phase 2)Study completedNCT03812029
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Enyo Pharma 120
Next Page